Stock screenerAll disclosures →
EDGAR →
CGON
Conviction 78HealthcareScan · Mon, Aug 10, 2026CGON$76.53+1.90%
ResistanceSupportVol 14Insider buyInsider sell2
Vol MA14 849.33K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price76.53
Change+1.90%
Gap+0.28%
Rel volume1.40×
Avg volume917.98K
Avg $ vol66.09M
SMA 2071.84
SMA 5067.27
SMA 20057.71
Price vs 50+13.77%
Price vs 200+32.61%
MA stackbullish
50/200 cross—
Supertrendup · 64.87
RSI (14)61
MACD hist0.28
MACD crossbull · 1d
Stoch %K / %D99 / 89
ADX (14)34
+DI / −DI21 / 10
RSI divergence—
MACD divergenceBullish
ATR %+4.73%
ADR %4.98%
52w high76.53
52w low23.95
From 52w high+0.00%
Above 52w low+219.61%
New 52w highYes
SqueezeOn · 15d
Bollinger width11.48%
%B1.07
Donchian pos99.37%
Donchian high76.59
Donchian low67.12
AVWAP (52w high)71.70
vs AVWAP high+6.73%
AVWAP (52w low)54.46
vs AVWAP low+40.52%
OBV trendFlat
Chaikin MF (20)0.06
Today vs 20d1.40×
Avg vol (14d)849.33K
Avg vol (20d)917.98K
Avg $ vol (20d)66.09M
Market cap6.78B
RS 3m (vs SPY)+2.86%
RS 6m (vs SPY)+38.53%
RS line new highNo
Trend template8/8
Technical rank87.5
1 week+10.67%
1 month+1.71%
3 months+9.93%
6 months+51.97%
1 year+214.29%
YTD+83.13%
P/E-42.14
P/B6.59
P/S—
P/FCF-51.21
EPS-2.08
Div yield—
ROE-15.64%
ROA-14.83%
Debt/Eq0.00
Current22.22
EV/EBITDA-35.74
Gross margin—
Net margin—
Rev growth254.70%
EPS growth-82.87%
Price target91.27
Target upside19.26%
Analyst ratingBuy
Institutional111.65%
Ent. value6.77B
Revenue1.16M
Net income-79.06M
Gross profit—
Free cash flow-132.48M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out88.2M
Employees142
ListedThu, Jan 25, 2024
Free float55.61M
Float %68.9%
Short interest12.11M
Days to cover12.2d
Short volume58.6%
Squeeze score83 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.90 vs −$0.70
Last surprise-28.6% miss
Setup gradeA
Conviction78 / 100
Pattern quality—
Tech rank87.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance76.43
Support67.28
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CGON
No recent disclosed trades by Congress in CGON. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CGON · 5 buys · 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
POST LEONARD E Director · Common Stock · 2026-07-15 | Exercise | 1K | $600 | 2026-07-15 | 2026-07-17 |
POST LEONARD E Director · Common Stock · 2026-07-15 | Sell | 1K | $71K | 2026-07-15 | 2026-07-17 |
POST LEONARD E Director · Director Stock Option (right to buy) · 2026-07-15 | Exercise | 1K | — | 2026-07-15 | 2026-07-17 |
Liu Brian Guan-Chyun Director · Common Stock · 2026-06-25 | Buy | 371.08K | $25M | 2026-06-25 | 2026-06-29 |
POST LEONARD E Director · Common Stock · 2026-06-24 | Exercise | 5K | $3K | 2026-06-24 | 2026-06-25 |
POST LEONARD E Director · Common Stock · 2026-06-24 | Sell | 5K | $350K | 2026-06-24 | 2026-06-25 |
POST LEONARD E Director · Director Stock Option (right to buy) · 2026-06-24 | Exercise | 5K | — | 2026-06-24 | 2026-06-25 |
Mulay James Director · Common Stock · 2026-06-15 | Exercise | 654 | $2K | 2026-06-15 | 2026-06-16 |
Mulay James Director · Common Stock · 2026-06-15 | Sell | 654 | $39K | 2026-06-15 | 2026-06-16 |
Mulay James Director · Common Stock · 2026-06-15 | Exercise | 1.31K | $16K | 2026-06-15 | 2026-06-16 |
SEC filings
EDGAR filings in CGON · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.